Two Sigma Advisers’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.2K | Sell |
|
|||||
|
2025
Q1 | $101K | Buy |
|
|||||
|
2024
Q4 | $43.7K | Buy |
|
|||||
|
2024
Q3 | $19.1K | Sell |
|
|||||
|
2024
Q2 | $22.4K | Sell |
|
|||||
|
2024
Q1 | $48K | Sell |
|
|||||
|
2023
Q4 | $41.3K | Sell |
|
|||||
|
2023
Q3 | $46.1K | Sell |
|
|||||
|
2023
Q2 | $69.9K | Sell |
|
|||||
|
2023
Q1 | $101K | Sell |
|
|||||
|
2022
Q4 | $104K | Sell |
|
|||||
|
2022
Q3 | $249K | Sell |
|
|||||
|
2022
Q2 | $416K | Sell |
|
|||||
|
2022
Q1 | $948K | Sell |
|
|||||
|
2021
Q4 | $2.67M | Sell |
|
|||||
|
2021
Q3 | $2.8M | Sell |
|
|||||
|
2021
Q2 | $5.2M | Buy |
|
|||||
|
2021
Q1 | $3.84M | Buy |
|
|||||
|
2020
Q4 | $897K | Buy |
|
|||||
|
2020
Q3 | $316K | Buy |
|
|||||
|
2020
Q2 | $254K | Buy |
|
|||||
|
2020
Q1 | $193K | Sell |
|
|||||
|
2019
Q4 | $219K | Buy |
|
|||||
|
2019
Q3 | $184K | Buy |
|
|||||
|
2019
Q2 | $187K | Buy |
|
|||||
|
2019
Q1 | $186K | Sell |
|
|||||
|
2018
Q4 | $141K | Buy |
|
|||||
|
2018
Q3 | $198K | Sell |
|
|||||
|
2018
Q2 | $193K | Buy |
|
|||||
|
2018
Q1 | $167K | Sell |
|
|||||
|
2017
Q4 | $194K | Buy |
|
|||||
|
2017
Q3 | $49K | Buy |
|
|||||
|
2017
Q2 | $42K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $37K | Sell |
|
|||||
|
2016
Q3 | $47K | Buy |
|